Archives
-
KX2-391 Dihydrochloride: Assay Design Guide
2026-08-20
KX2-391 dihydrochloride is more than a dual Src–tubulin research compound. This assay-focused guide explains how to separate its direct molecular activities, interpret cross-domain data, and design credible oncology, HBV, and BoNT/A experiments.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-08-20
The reference study identifies a double-positive feedback loop in which metabolic stress activates SQSTM1/p62 and AMPK, while AMPK activity further promotes SQSTM1 expression and phosphorylation. This circuit coordinates KEAP1 degradation, NFE2L2/NRF2 activation, and antioxidant adaptation, offering a mechanistic explanation for stress tolerance in STK11- and KEAP1-altered lung cancer cells.
-
OsCPK4–OsCNGC7 Loop Improves Rice Salt Tolerance
2026-08-19
The 2026 reference study identifies an OsCPK4–OsCNGC7 phosphorylation-centered module that dynamically controls calcium influx during salt stress in rice. Its phase-dependent regulation links rapid stress signaling with later growth recovery, offering a mechanistic framework for protein phosphorylation analysis in plant stress biology.
-
3X (DYKDDDDK) Peptide for IDH1 Workflows
2026-08-19
Use the 3X (DYKDDDDK) Peptide to streamline FLAG-tagged protein capture, elution, and detection while preserving options for structural and metal-sensitive assays. This practical workflow connects 3X FLAG peptide handling with the reference study’s chemoproteomic analysis of IDH1-R132H autopalmitoylation.
-
Carvedilol Phosphate for IRI Research
2026-08-18
Carvedilol Phosphate provides a practical way to perturb beta-adrenergic signaling across cardiovascular and hepatic ischemia–reperfusion workflows. This guide connects formulation choices, hepatocyte–macrophage assays, and troubleshooting strategies without overstating evidence from the latest Arrb2 study.
-
Dlin-MC3-DMA: From Lipid to Assay Decision
2026-08-18
Dlin-MC3-DMA is an ionizable cationic liposome lipid whose value depends on cargo, formulation, and assay design. This guide connects its endosomal mechanism with machine-learning evidence to improve siRNA and mRNA delivery decisions.
-
DAMGO: From Receptor Signal to Pain Phenotype
2026-08-17
DAMGO is a selective µ-opioid receptor agonist for connecting receptor-proximal signaling with pain behavior. This article explains how to interpret its affinity, functional assays, and circuit-level findings without confusing receptor activation with universal analgesia.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-08-17
This study identifies striatal dopamine D2 receptor-expressing medium spiny neurons as a cell-type-specific circuit component associated with autistic-like repetitive behaviors after Neuroligin 1 loss. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the authors link D2-MSN hyperactivity and excessive PKC signaling to repetitive self-grooming and digging.
-
Tirbanibulin in HPV-Positive HeLa Cells
2026-08-16
This 2024 study shows that tirbanibulin suppresses proliferation of HPV-18-containing HeLa cells while reducing protein expression across Src–MEK-associated, cell-cycle, invasion, and survival pathways. Its integrated immunoblotting approach provides a mechanistic framework for understanding how an approved actinic keratosis treatment may also affect HPV-associated oncogenic signaling, while leaving direct antiviral and clinical efficacy questions unresolved.
-
ATM Inhibition and Fenofibrate in HGSOC
2026-08-15
The reference study identifies a metabolic vulnerability associated with ATM activity in high-grade serous ovarian cancer (HGSOC). It shows that pharmacologic ATM inhibition can synergize with fenofibrate, a PPARα agonist, to induce senescence in HGSOC cells, offering a combination strategy that extends beyond conventional DNA damage-based treatment.
-
AZD0156: Reliable ATM Inhibition in Viability Assays
2026-08-14
Learn how AZD0156 (SKU B7822) can support better-controlled cell viability, proliferation, and cytotoxicity studies by combining selective ATM pathway inhibition with practical formulation guidance. This scenario-driven guide addresses metabolic assay confounding, solvent compatibility, protocol design, interpretation, and product-selection criteria.
-
AMD-070 Hydrochloride: CXCR4 Research
2026-08-14
AMD-070 hydrochloride is a selective CXCR4 antagonist for studying CXCR4/CXCL12 biology, immune-cell trafficking, and disease-relevant phenotypes. This article translates clinical findings in WHIM syndrome into practical assay decisions centered on dynamic rather than single-timepoint readouts.
-
Q-VD(OMe)-OPh: Pan-Caspase Inhibition Guide
2026-08-13
Q-VD(OMe)-OPh is a broad-spectrum pan-caspase inhibitor for controlled apoptosis experiments. Its recombinant-caspase activity profile and low reported cytotoxicity make it useful for apoptosis assay design, pathway dissection, and interpretation of complex cell-death models.
-
Ionomycin Free Acid for Reliable Calcium Assays
2026-08-13
This scenario-driven guide explains how Ionomycin free acid, SKU B6947, can support controlled calcium ion transport, intracellular calcium increase, and compatible viability or signaling workflows. It covers assay design, protocol optimization, data interpretation, and practical reagent-selection criteria grounded in product specifications and relevant FAK research.
-
Cardamomin Protects Against Oxidative Ischemic Injury
2026-08-12
The reference study links cardamomin from Amomum villosum stems and leaves to protection against hydrogen peroxide-induced oxidative damage and permanent cerebral ischemia. Its central contribution is a multi-level mechanism involving MEK/ERK-driven NRF2 activation, suppression of oxeiptosis and parthanatos, and improved tissue viability in a rat stroke model.